![]() ![]() ![]() And that’s looking to see if you could get lupus nephritis under control using that. And that’s a type 2 anti-CD20 monoclonal antibody, and that differs from rituximab which was a type 1 anti-CD20 monoclonal antibody. Obinutuzumab, it’s in a phase 3 study right now with Dr Furie being one of the lead authors on lead on that study, and it’s called ALLEGORY. There are some other drugs that are in the pipeline that are also biologics, and I believe one is a small molecule. We have belimumab and anifrolumab, which have been FDA approved for Systemic lupus erythematosus, and belimumab has been approved for Lupus Nephritis. Mizelle, MD, MPH, FACR: There’s several different agents that have been tried, of course as far as biologics are concerned, and then also some small molecules. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |